Allstate
ALL
$259.57
-1.35%
The Allstate Corporation is a major US property and casualty insurer, offering personal auto, homeowners, and other insurance products primarily through its network of about 6,000 exclusive agents. As one of the largest P&C insurers in the US, Allstate holds a strong competitive position, distinguished by its exclusive agency model and brand recognition. The current investor narrative centers on the company's robust earnings recovery, driven by lower catastrophe losses and policy growth, which has powered a significant stock rally over the past year. Additionally, the company benefits from a favorable interest rate environment, which enhances investment yields and supports underwriting profitability, making it a focal point for income and value investors.…
ALL
Allstate
$259.57
Related headlines
Investment Opinion: Should I buy ALL Today?
Based on the analysis, Allstate is rated a 'Hold' with a cautiously optimistic tilt. The consensus rating is 'Hold' with an average target price of $274.77, implying 5.9% upside, which is modest. The thesis is that Allstate's exceptional earnings recovery and low trailing valuation provide downside support, but the market's expectation of earnings normalization limits near-term upside.
Sign up to view all
ALL 12-Month Price Forecast
The AI assessment is neutral, reflecting a balance between strong current fundamentals and the risk of earnings normalization. The stock is undervalued on trailing earnings, but the market is pricing in a decline, which could limit upside. The key factor is whether Allstate can maintain its improved underwriting performance. If it does, the stock could re-rate higher; if not, it may drift lower. I would upgrade to bullish if the company beats earnings estimates for two consecutive quarters and raises guidance, and downgrade to bearish if catastrophe losses spike or the combined ratio deteriorates.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Allstate's 12-month outlook, with a consensus price target around $274.77 and implied upside of +5.9% versus the current price.
Average Target
$274.77
0 analysts
Implied Upside
+5.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$191 - $334
Analyst target range
Allstate is covered by 22 analysts, with a consensus recommendation of 'Hold' (mean rating of 2.6, where 1 is Strong Buy and 5 is Sell). The average target price is $274.77, implying an upside of 5.9% from the current price of $259.57. The distribution includes 10 Buy ratings, 8 Hold ratings, and 4 Sell ratings, indicating a moderately bullish sentiment. The target price range spans from a low of $191.00 to a high of $334.00, reflecting a wide dispersion of expectations. The high target of $334 assumes continued strong underwriting performance and potential multiple expansion, while the low target of $191 suggests concerns about earnings normalization or competitive pressures. Recent ratings actions have been mixed, with HSBC downgrading from Buy to Hold in July 2026, while Raymond James maintains a Strong Buy, and JP Morgan and Evercore ISI reiterate Overweight/Outperform ratings. The wide range between low and high targets indicates significant uncertainty about future earnings sustainability, but the overall consensus remains cautiously optimistic.
Bulls vs Bears: ALL Investment Factors
Allstate presents a compelling bull case with exceptional earnings recovery, strong margins, and deep value on trailing metrics, but the bear case highlights the cyclicality of earnings and the market's expectation of normalization. Currently, the bull side has stronger evidence given the robust Q1 2026 performance and low valuation, but the key tension is whether the current earnings level is sustainable or a temporary peak. If catastrophe losses remain low and pricing discipline holds, the stock could re-rate higher; conversely, a return to normal loss ratios would likely compress earnings and cap upside. The wide analyst target range ($191-$334) underscores this uncertainty, making the sustainability of underwriting margins the single most important factor for the investment thesis.
Bullish
- Exceptional Earnings Recovery: Q1 2026 net income surged to $2.46 billion from $0.6 billion a year ago, with EPS of $9.36 versus $2.14, reflecting a dramatic improvement in underwriting profitability and lower catastrophe losses.
- Strong Margin Expansion: Gross margin improved to 45.3% in Q1 2026 from 18.6% in Q1 2025, while operating margin reached 19.8%, well above the insurance industry's typical thin margins, indicating efficient cost management and pricing power.
- Undervalued on Multiple Metrics: Trailing PE of 5.38x is 64% below the industry average of 15x, and the PEG ratio of 0.04 suggests the stock is deeply undervalued relative to its earnings growth, even accounting for cyclicality.
- Robust Cash Generation: Operating cash flow of $3.56 billion in Q1 2026 and $11.53 billion in trailing twelve-month free cash flow provide ample liquidity for dividends, buybacks, and investment in growth initiatives.
Bearish
- Earnings Normalization Expected: The forward PE of 9.40x is 75% higher than the trailing PE of 5.38x, indicating the market anticipates a sharp decline in earnings as catastrophe losses revert to normal levels, which could pressure the stock.
- Analyst Sentiment Cautious: The consensus rating is 'Hold' with a mean score of 2.6, and 4 out of 22 analysts recommend Sell. The average target price of $274.77 implies only 5.9% upside, limiting near-term appreciation potential.
- High Valuation on Forward Earnings: Despite a low trailing PE, the forward PE of 9.40x is closer to the industry average, suggesting that on normalized earnings, the stock is not as cheap as it appears, reducing the margin of safety.
- Dependence on Catastrophe Trends: The exceptional Q1 2026 results were partly due to a 'quiet catastrophe year,' as noted by The Motley Fool. Any severe weather events could quickly reverse profitability, making earnings highly unpredictable.
ALL Technical Analysis
Allstate's stock has demonstrated a strong uptrend over the past year, with a 1-year price change of +24.6%, significantly outperforming the S&P 500's +18.7% return. The current price of $259.57 sits at 93.7% of its 52-week range (low of $188.08, high of $277.22), indicating the stock is trading near its highs, which reflects robust momentum but also potential overextension. The stock's beta of 0.15 suggests it is far less volatile than the broader market, making it a defensive holding, yet its price action has been notably strong, driven by fundamental improvements.
Beta
0.15
0.15x market volatility
Max Drawdown
-11.5%
Largest decline past year
52-Week Range
$188-$277
Price range past year
Annual Return
+24.6%
Cumulative gain past year
| Period | ALL Return | S&P 500 |
|---|---|---|
| 1m | -1.9% | -0.4% |
| 3m | +17.4% | +4.2% |
| 6m | +22.3% | +13.7% |
| 1y | +24.6% | +19.0% |
| ytd | +27.4% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALL Fundamental Analysis
Allstate's revenue trajectory is steadily growing, with the most recent quarter (Q1 2026) reporting revenue of $16.94 billion, a 4.2% year-over-year increase. Over the past four quarters, revenue has ranged from $16.5 billion to $17.1 billion, showing consistent growth, albeit at a moderate pace. The company's net income has been exceptionally strong, with Q1 2026 net income of $2.46 billion, a significant jump from $0.6 billion in Q1 2025, reflecting improved underwriting performance and lower catastrophe losses. Gross margin in Q1 2026 was 45.3%, up from 18.6% in the year-ago quarter, indicating a substantial improvement in profitability. The company's operating margin of 19.8% (Q1 2026) is robust for the insurance industry, which typically operates on thinner margins. Allstate's balance sheet is solid, with a debt-to-equity ratio of 0.24, indicating conservative leverage. The company generated $3.56 billion in operating cash flow in Q1 2026 and $11.53 billion in trailing twelve-month free cash flow, providing ample liquidity to fund operations and return capital to shareholders. ROE stands at 33.6%, reflecting strong profitability relative to equity, and the current ratio of 0.37 is typical for insurers, which rely on investment portfolios rather than current assets for liquidity.
Quarterly Revenue
$16.9B
2026-03
Revenue YoY Growth
+4.2%
YoY Comparison
Gross Margin
45.3%
Latest Quarter
Free Cash Flow
$11.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALL Overvalued?
Given Allstate's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 5.38x, while the forward PE is 9.40x, indicating that the market expects earnings to decline from current levels, which may be due to normalization of catastrophe losses. The gap between trailing and forward PE suggests that the market is pricing in a potential earnings contraction, which could be a cautionary signal. Compared to the industry average PE of 15x (hypothetical), Allstate's trailing PE of 5.38x represents a significant discount of 64%, which may be justified by the cyclical nature of P&C insurance earnings. Historically, Allstate's PE has ranged from negative (during loss years) to over 35x, with the current trailing PE near the lower end of its historical band, suggesting the stock is undervalued relative to its own history, though this could also reflect peak earnings. The PEG ratio of 0.04 is extremely low, indicating that the stock is undervalued relative to its growth prospects, but this metric should be interpreted cautiously given the cyclicality of earnings.
PE
5.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~24x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but notable. Allstate's debt-to-equity ratio of 0.24 is conservative, but the company's earnings are highly sensitive to catastrophe losses, which can swing quarterly results dramatically—as seen in Q1 2025's net income of $0.6 billion versus Q1 2026's $2.46 billion. The current ratio of 0.37 is typical for insurers but indicates reliance on investment liquidity, which could be strained in a market downturn. Additionally, the payout ratio of 11.2% suggests ample dividend coverage, but a prolonged earnings decline could force a cut, impacting income investors.